CAM
AZN icon

Capstone Asset Management’s AstraZeneca AZN Stock Holding History

Capstone Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$3.29M Sell
48,241
-3,495
-7% -$228K 0.09% 261
2017
Q1 		$3.22M Buy
51,736
+3,330
+7% +$194K 0.09% 262
2016
Q4 		$2.65M Buy
48,406
+215
+0.4% +$12.2K 0.08% 309
2016
Q3 		$3.17M Sell
48,191
-30
-0.1% -$1.96K 0.09% 268
2016
Q2 		$2.91M Buy
48,221
+2,745
+6% +$159K 0.09% 276
2016
Q1 		$2.56M Sell
45,476
-687
-1% -$41.3K 0.07% 324
2015
Q4 		$3.13M Buy
46,163
+2,024
+5% +$133K 0.09% 279
2015
Q3 		$2.81M Buy
44,139
+1,065
+2% +$70.1K 0.09% 289
2015
Q2 		$2.74M Buy
43,074
+70
+0.2% +$4.79K 0.08% 310
2015
Q1 		$2.94M Buy
43,004
+7,310
+20% +$508K 0.08% 294
2014
Q4 		$2.51M Buy
35,694
+6,636
+23% +$475K 0.07% 313
2014
Q3 		$2.08M Buy
29,058
+100
+0.3% +$7.32K 0.07% 326
2014
Q2 		$2.15M Sell
28,958
-140
-0.5% -$10.1K 0.07% 324
2014
Q1 		$1.89M Buy
29,098
+360
+1% +$23.3K 0.06% 377
2013
Q4 		$1.71M Buy
28,738
+2,660
+10% +$145K 0.05% 419
2013
Q3 		$1.35M Sell
26,078
-9,428
-27% -$474K 0.03% 613
2013
Q2 		$1.68M Buy
+35,506
New +$1.81M 0.04% 480

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Capstone Asset Management's AZN Position: Q2 2017 in Review

Capstone Asset Management reduced its AstraZeneca (AZN) stake by 6.8% in Q2 2017, selling an estimated $228K and leaving 48,241 shares worth $3.29M. The position accounts for 0.09% of the portfolio, ranked #261.

Capstone Asset Management first reported a position in AZN in Q2 2013 and has held it in 17 quarters since. 465 funds tracked by Wall St. Rank hold AZN as of Q2 2017.

  • Capstone Asset Management held 48,241 shares of AstraZeneca worth $3.29M as of Q2 2017.
  • Capstone Asset Management sold 3,495 AstraZeneca shares in Q2 2017, an estimated $228K.
  • AstraZeneca made up 0.09% of Capstone Asset Management's portfolio in Q2 2017, its #261 holding.
  • Capstone Asset Management first reported a position in AstraZeneca in Q2 2013 and has held it in 17 quarters since.
  • 465 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.